10-Q 1 nvts-20230331.htm 10-Q nvts-20230331
false00018217692023Q112/31252P3DP3DP3DP4Y00018217692023-01-012023-03-310001821769us-gaap:CommonClassAMember2023-05-10xbrli:shares0001821769us-gaap:CommonClassBMember2023-05-1000018217692023-03-31iso4217:USD00018217692022-12-31iso4217:USDxbrli:shares0001821769srt:AffiliatedEntityMember2023-01-012023-03-310001821769srt:AffiliatedEntityMember2022-01-012022-03-3100018217692022-01-012022-03-310001821769us-gaap:CommonStockMember2022-12-310001821769us-gaap:AdditionalPaidInCapitalMember2022-12-310001821769us-gaap:RetainedEarningsMember2022-12-310001821769us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001821769us-gaap:NoncontrollingInterestMember2022-12-310001821769us-gaap:CommonStockMember2023-01-012023-03-310001821769us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001821769us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001821769us-gaap:RetainedEarningsMember2023-01-012023-03-310001821769us-gaap:CommonStockMember2023-03-310001821769us-gaap:AdditionalPaidInCapitalMember2023-03-310001821769us-gaap:RetainedEarningsMember2023-03-310001821769us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001821769us-gaap:NoncontrollingInterestMember2023-03-310001821769us-gaap:CommonStockMember2021-12-310001821769us-gaap:AdditionalPaidInCapitalMember2021-12-310001821769us-gaap:RetainedEarningsMember2021-12-310001821769us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001821769us-gaap:NoncontrollingInterestMember2021-12-3100018217692021-12-310001821769us-gaap:CommonStockMember2022-01-012022-03-310001821769us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001821769us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001821769us-gaap:RetainedEarningsMember2022-01-012022-03-310001821769us-gaap:CommonStockMember2022-03-310001821769us-gaap:AdditionalPaidInCapitalMember2022-03-310001821769us-gaap:RetainedEarningsMember2022-03-310001821769us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001821769us-gaap:NoncontrollingInterestMember2022-03-3100018217692022-03-310001821769nvts:VDDTechMember2022-06-102022-06-100001821769nvts:GeneSicSemiconductorsIncMember2022-08-012022-08-310001821769nvts:ICJointVentureMember2023-01-012023-01-310001821769us-gaap:FurnitureAndFixturesMember2023-03-310001821769us-gaap:FurnitureAndFixturesMember2022-12-310001821769nvts:ComputerAndOtherEquipmentMember2023-03-310001821769nvts:ComputerAndOtherEquipmentMember2022-12-310001821769us-gaap:LeaseholdImprovementsMember2023-03-310001821769us-gaap:LeaseholdImprovementsMember2022-12-310001821769us-gaap:ConstructionInProgressMember2023-03-310001821769us-gaap:ConstructionInProgressMember2022-12-310001821769us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2023-01-012023-03-310001821769srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2023-01-012023-03-310001821769nvts:ComputerAndOtherEquipmentMembersrt:MinimumMember2023-01-012023-03-310001821769srt:MaximumMembernvts:ComputerAndOtherEquipmentMember2023-01-012023-03-310001821769us-gaap:LeaseholdImprovementsMembersrt:MinimumMember2023-01-012023-03-310001821769srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2023-01-012023-03-310001821769us-gaap:FairValueInputsLevel1Member2023-03-310001821769us-gaap:FairValueInputsLevel1Member2022-12-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769us-gaap:FairValueInputsLevel2Membernvts:EarnoutSharesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769us-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769us-gaap:FairValueInputsLevel2Membernvts:EarnoutSharesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769us-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-03-310001821769nvts:EarnoutSharesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001821769nvts:VDDTechMember2022-12-310001821769nvts:VDDTechMember2023-01-012023-03-310001821769nvts:VDDTechMember2023-03-310001821769us-gaap:TradeNamesMember2023-03-310001821769us-gaap:TradeNamesMember2023-01-012023-03-310001821769us-gaap:DevelopedTechnologyRightsMember2023-03-310001821769us-gaap:DevelopedTechnologyRightsMembersrt:MinimumMember2023-01-012023-03-310001821769srt:MaximumMemberus-gaap:DevelopedTechnologyRightsMember2023-01-012023-03-310001821769us-gaap:InProcessResearchAndDevelopmentMember2023-03-310001821769us-gaap:PatentedTechnologyMember2023-03-310001821769us-gaap:PatentedTechnologyMembersrt:MinimumMember2023-01-012023-03-310001821769srt:MaximumMemberus-gaap:PatentedTechnologyMember2023-01-012023-03-310001821769us-gaap:CustomerRelationshipsMember2023-03-310001821769us-gaap:CustomerRelationshipsMember2023-01-012023-03-310001821769us-gaap:NoncompeteAgreementsMember2023-03-310001821769us-gaap:NoncompeteAgreementsMember2023-01-012023-03-310001821769us-gaap:OtherIntangibleAssetsMember2023-03-310001821769us-gaap:OtherIntangibleAssetsMember2023-01-012023-03-310001821769nvts:TermLoanMemberus-gaap:SecuredDebtMember2020-04-290001821769srt:MinimumMember2023-03-310001821769srt:MaximumMember2023-03-3100018217692022-01-01xbrli:pure0001821769us-gaap:EmployeeStockOptionMembernvts:EquityIncentivePlan2020Member2020-08-052020-08-050001821769us-gaap:EmployeeStockOptionMembernvts:EquityIncentivePlan2020Member2023-01-012023-03-310001821769nvts:EquityIncentivePlan2020Member2020-08-050001821769us-gaap:EmployeeStockOptionMembernvts:EquityIncentivePlan2020Member2021-10-192021-10-190001821769us-gaap:RestrictedStockMembernvts:EquityIncentivePlan2020Member2021-10-192021-10-190001821769nvts:EquityIncentivePlan2021Member2021-08-170001821769nvts:EquityIncentivePlan2021Member2023-01-012023-03-3100018217692021-10-190001821769us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001821769us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001821769us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310001821769us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-03-3100018217692022-01-012022-12-310001821769us-gaap:EmployeeStockMember2023-01-012023-03-310001821769us-gaap:EmployeeStockMember2022-01-012022-03-310001821769nvts:LongTermIncentivePlanStockOptionsMember2023-01-012023-03-310001821769nvts:LongTermIncentivePlanStockOptionsMember2022-01-012022-03-310001821769us-gaap:EmployeeStockMember2023-03-310001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2021-12-292021-12-290001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2021-12-29nvts:hurdle0001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMembersrt:MinimumMember2021-12-292021-12-290001821769nvts:LongTermIncentivePlanStockOptionsMembersrt:MaximumMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2021-12-292021-12-290001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMembernvts:BlackScholesAndMonteCarloModelMemberMember2021-12-292021-12-290001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2023-01-012023-03-310001821769nvts:LongTermIncentivePlanStockOptionsMember2021-12-292021-12-290001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:December292021Member2023-01-012023-03-310001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:December292021Member2022-01-012022-03-310001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:December292021Member2023-03-310001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2022-08-152022-08-150001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2022-08-150001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:EquityIncentivePlan2021Membersrt:ManagementMembersrt:MinimumMember2022-08-152022-08-150001821769nvts:LongTermIncentivePlanStockOptionsMembersrt:MaximumMembernvts:EquityIncentivePlan2021Membersrt:ManagementMember2022-08-152022-08-150001821769nvts:LongTermIncentivePlanStockOptionsMember2022-08-152022-08-150001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:August152022Member2023-01-012023-03-310001821769nvts:LongTermIncentivePlanStockOptionsMembernvts:August152022Member2023-03-310001821769us-gaap:RestrictedStockUnitsRSUMember2021-08-252021-08-250001821769us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMember2021-08-252021-08-250001821769us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMember2021-08-25nvts:installment0001821769us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2021-08-252021-08-250001821769us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2021-08-252021-08-250001821769nvts:ShareBasedPaymentArrangementTrancheFourMemberus-gaap:RestrictedStockUnitsRSUMember2021-08-252021-08-250001821769us-gaap:RestrictedStockUnitsRSUMember2022-12-310001821769us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001821769us-gaap:RestrictedStockUnitsRSUMember2023-03-310001821769us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001821769nvts:AnnualBonusPlan2023Member2023-03-310001821769nvts:AnnualBonusPlan2022Member2022-12-310001821769nvts:AnnualBonusPlan2022Member2023-03-310001821769nvts:FormerEmployeesMembernvts:ICJointVentureMember2023-01-192023-01-190001821769nvts:EarnoutSharesMember2023-01-012023-03-310001821769nvts:EarnoutSharesMember2022-01-012022-03-310001821769us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMembernvts:EquityIncentivePlan2020Member2023-03-310001821769us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMembernvts:EquityIncentivePlan2020Member2023-03-310001821769nvts:TheWarrantsMember2021-10-190001821769nvts:PublicWarrantsMembernvts:LiveOakAcquisitionCorpIIMember2021-10-190001821769us-gaap:CommonClassAMembernvts:PublicWarrantsMember2021-10-190001821769us-gaap:CommonClassAMembernvts:PrivatePlacementWarrantsMember2021-10-190001821769nvts:PrivatePlacementWarrantsMember2021-10-190001821769nvts:ClassAOrdinarySharesMembernvts:PrivatePlacementWarrantsMember2021-10-190001821769nvts:TheWarrantsMember2021-10-192021-10-190001821769nvts:RedemptionOptionOneMemberus-gaap:CommonClassAMembernvts:PublicWarrantsMember2021-10-192021-10-190001821769nvts:RedemptionOptionOneMemberus-gaap:CommonClassAMembernvts:PublicWarrantsMember2021-10-190001821769nvts:RedemptionOptionOneMemberus-gaap:CommonClassAMembernvts:PublicWarrantsMembersrt:MinimumMember2021-10-192021-10-19nvts:day0001821769nvts:RedemptionOptionOneMembernvts:PublicWarrantsMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:PublicWarrantsMembernvts:RedemptionOptionTwoMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:PublicWarrantsMembernvts:RedemptionOptionTwoMember2021-10-190001821769us-gaap:CommonClassAMembernvts:PublicWarrantsMembersrt:MinimumMembernvts:RedemptionOptionTwoMember2021-10-192021-10-190001821769nvts:PublicWarrantsMembernvts:RedemptionOptionTwoMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:PublicWarrantsMembernvts:RedemptionOptionThreeMember2021-10-190001821769us-gaap:CommonClassAMembernvts:PublicWarrantsMembersrt:MinimumMembernvts:RedemptionOptionThreeMember2021-10-192021-10-190001821769nvts:PublicWarrantsMembernvts:RedemptionOptionThreeMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:TheWarrantsMember2021-10-190001821769us-gaap:CommonClassAMembernvts:TheWarrantsMember2020-12-020001821769us-gaap:CommonClassAMembernvts:TheWarrantsMember2022-02-220001821769us-gaap:CommonClassAMembernvts:TheWarrantsMember2022-02-040001821769nvts:TheWarrantsMember2022-02-040001821769nvts:TheWarrantsMember2022-02-042022-02-0400018217692022-02-030001821769us-gaap:CommonClassAMembernvts:EarnoutSharesMember2021-10-192021-10-190001821769nvts:EarnoutSharesMember2021-10-192021-10-190001821769nvts:TriggeringEvent1Memberus-gaap:CommonClassAMembernvts:EarnoutSharesMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:TriggeringEvent2Membernvts:EarnoutSharesMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:TriggeringEvent3Membernvts:EarnoutSharesMember2021-10-192021-10-190001821769us-gaap:CommonClassAMembernvts:EarnoutSharesMember2021-10-190001821769us-gaap:MeasurementInputRiskFreeInterestRateMembernvts:EarnoutSharesMember2023-03-310001821769us-gaap:MeasurementInputRiskFreeInterestRateMembernvts:EarnoutSharesMember2022-12-310001821769nvts:EarnoutSharesMemberus-gaap:MeasurementInputPriceVolatilityMember2023-03-310001821769nvts:EarnoutSharesMemberus-gaap:MeasurementInputPriceVolatilityMember2022-12-310001821769us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310001821769us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001821769us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-01-012023-03-310001821769nvts:GeneSicSemiconductorsIncMember2023-03-310001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2023-03-310001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:MeasurementInputOptionVolatilityMember2023-03-310001821769us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembernvts:DistributorAMember2023-01-012023-03-310001821769nvts:DistributorBMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001821769us-gaap:RevenueFromContractWithCustomerMembernvts:DistributorCMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001821769us-gaap:RevenueFromContractWithCustomerMembernvts:DistributorCMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001821769us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembernvts:DistributorDMember2022-01-012022-03-310001821769nvts:DistributorEMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001821769us-gaap:RevenueFromContractWithCustomerMembersrt:EuropeMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310001821769us-gaap:RevenueFromContractWithCustomerMembersrt:EuropeMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-03-310001821769country:CNus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310001821769country:CNus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-03-310001821769country:USus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310001821769country:USus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-03-310001821769nvts:RestOfAsiaMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310001821769nvts:RestOfAsiaMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-03-310001821769nvts:AllOtherCountriesMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310001821769nvts:AllOtherCountriesMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-03-310001821769us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310001821769us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-03-310001821769us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernvts:DistributorAMember2023-01-012023-03-310001821769us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernvts:DistributorAMember2022-01-012022-06-300001821769nvts:DistributorBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001821769nvts:DistributorBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-06-300001821769us-gaap:AccountsReceivableMembernvts:DistributorCMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001821769nvts:EarnoutSharesMember2023-01-012023-03-310001821769nvts:EarnoutSharesMember2022-01-012022-03-310001821769us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001821769us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001821769us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001821769us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001821769srt:AffiliatedEntityMembernvts:NoteReceivableWithAnEmployeeMembersrt:MinimumMember2023-01-012023-03-310001821769srt:AffiliatedEntityMembersrt:MaximumMembernvts:NoteReceivableWithAnEmployeeMember2023-01-012023-03-310001821769srt:AffiliatedEntityMembernvts:NoteReceivableWithAnEmployeeMember2022-01-012022-12-310001821769nvts:ICJointVentureMember2023-01-192023-01-190001821769nvts:JointVentureInvestmentMemberus-gaap:CorporateJointVentureMember2023-01-012023-03-310001821769nvts:JointVentureInvestmentMemberus-gaap:CorporateJointVentureMember2022-01-012022-03-310001821769srt:AffiliatedEntityMembernvts:JointVentureInvestmentMember2022-07-012022-09-300001821769srt:AffiliatedEntityMembernvts:JointVentureInvestmentMember2023-01-012023-03-310001821769srt:AffiliatedEntityMembernvts:JointVentureInvestmentMember2023-03-310001821769us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMembernvts:VDDTechMember2022-06-102022-06-100001821769us-gaap:RestrictedStockUnitsRSUMembernvts:VDDTechMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-06-102022-06-100001821769nvts:VDDTechMember2022-06-300001821769nvts:VDDTechMember2022-07-012022-09-300001821769nvts:VDDTechMemberus-gaap:DevelopedTechnologyRightsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMember2022-06-100001821769nvts:GeneSicSemiconductorsIncMember2022-08-150001821769nvts:GeneSicSemiconductorsIncMember2022-08-152022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:TradeNamesMember2022-08-152022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:DevelopedTechnologyRightsMember2022-08-152022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:PatentedTechnologyMember2022-08-152022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:CustomerRelationshipsMember2022-08-152022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:NoncompeteAgreementsMember2022-08-152022-08-150001821769nvts:GeneSicSemiconductorsIncMember2022-01-012022-12-310001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:DevelopedTechnologyRightsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMember2022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:CustomerRelationshipsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMember2022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:TrademarksAndTradeNamesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMember2022-08-150001821769us-gaap:PatentsMembernvts:GeneSicSemiconductorsIncMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMember2022-08-150001821769nvts:GeneSicSemiconductorsIncMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:NoncompeteAgreementsMemberus-gaap:MeasurementInputDiscountRateMember2022-08-150001821769us-gaap:MeasurementInputDiscountRateMembernvts:JointVentureInvestmentMember2022-08-190001821769us-gaap:PatentsMembernvts:JointVentureInvestmentMember2022-08-192022-08-190001821769us-gaap:PatentsMembernvts:JointVentureInvestmentMember2022-08-190001821769nvts:JointVentureInvestmentMember2023-01-192023-01-190001821769us-gaap:DevelopedTechnologyRightsMembernvts:JointVentureInvestmentMember2023-02-132023-02-130001821769us-gaap:DevelopedTechnologyRightsMembernvts:MeasurementInputRoyaltyRateMembernvts:JointVentureInvestmentMember2023-02-13



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission file number: 001-39755
Navitas Logo(R) (SELECT).jpg
Navitas Semiconductor Corporation
(Exact name of registrant as specified in its charter)
Delaware85-2560226
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
3520 Challenger Street90503-1640
Torrance,California
(Address of Principal Executive Offices)(Zip Code)
(844) 654-2642
Registrant’s telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock,
par value $0.0001 per share
NVTSNasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable
date: 160,932,436 shares of Class A Common Stock and 0 shares of Class B Common Stock were outstanding at May 10, 2023.

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
This quarterly report contains forward-looking statements. All statements other than statements of historical facts contained in this quarterly report, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as “may,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this quarterly report and are subject to a number of important risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, including risks and uncertainties relating to:
our financial and business performance;
our ability to realize benefits from the acquisition of GeneSiC Semiconductor Inc. on August 15, 2022;
our ability to realize the benefits of the Business Combination, which may be affected by, among other things, competition and our ability to grow and manage growth profitably;
changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;
our product development timeline and expected start of production;
the implementation, market acceptance and success of our business model;
our ability to scale in a cost-effective manner;
developments relating to our competitors and industry;
the impact of health epidemics, including the Covid-19 pandemic, on our business and the actions we may take in response thereto;
our ability to obtain and maintain intellectual property protection, and not infringe on the rights of the intellectual property rights others;
our status as an emerging growth company (as defined by U.S. federal law);
our future capital requirements and sources and uses of cash;
our ability to obtain funding for our operations;
our business, expansion plans and opportunities;
the outcome of any known and unknown litigation and regulatory proceedings; and
the risks and uncertainties described in the summary below, and in our annual report on Form 10-K in the section titled “Risk Factors.”
Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. Some of these risks and uncertainties may in the future be amplified by events we do not expect or cannot predict. Additionally, new risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. As a result of these factors, the forward-looking statements in this quarterly report may not prove to be accurate.
Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this quarterly report, whether as a result of any new information, future events, changed circumstances or otherwise. You should read this quarterly report completely, and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.





SUMMARY OF RISK FACTORS
The below summary of risk factors provides an overview of many of the risks we are exposed to in the normal course of our business activities. As a result, the below summary risks do not contain all of the information that may be important to you, and you should read the summary risks together with the more detailed and complete discussion of risks set forth under the heading “Risk Factors” in Part I, Item 1A of our annual report on Form 10-K and in Part II, Item 1A of this and our other quarterly reports on Form 10‑Q. Additional risks, beyond those summarized below or discussed elsewhere in this annual report, may apply to our activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate.
Consistent with the foregoing, we are exposed to a variety of risks, including risks associated with the following:
Risks Related to Our Business and Operations
Our success and future revenue depend on our ability to achieve design wins and to convince our current and prospective end customers to design our products into their product offerings.
To date we have been successful in introducing our leading-edge GaN power IC technology in mobile charging applications, such as wall chargers and adapters for mobile phones and laptop computers, and on motor drives for home appliances, where we believe we have achieved a market-leading position in GaN power ICs. Growth in demand for our products depends on achieving similar successes in other markets where we believe our technology provides comparable advantages, including consumer electronics, data center, solar and EV. Although we believe we are on track in these efforts, no assurance can be given that we will succeed in similarly displacing legacy silicon solutions in these other target markets.
Our August 2022 acquisition of GeneSiC Semiconductor Inc. (“GeneSiC”) was our first significant acquisition. We are devoting, and expect to continue to devote, significant time and attention to integrating GeneSiC with our existing operations teams. Given our relatively small size and relative inexperience with acquisitions, we expect to face challenges which present a number of risks to achieving the anticipated benefits of the acquisition. Our revenue, expenses, results of operations and financial condition could be materially adversely affected as a result.
Since we have significant operations and revenues in China, our business development plans, results of operations and financial condition may be materially and adversely affected by significant political, social and economic developments in China, including governmental or regulatory changes.
We rely on a single third-party wafer fabrication supplier and facility for the fabrication of semiconductor wafers for GaN ICs and a separate third-party wafer fabrication supplier and facility for the fabrication of semiconductor wafers for SiC MOSFETs, and on a limited number of suppliers of other materials. The failure of any of these facilities or suppliers, or of additional suppliers, to continue to supply wafers or other materials on a timely basis could harm our business and our financial results.
Increased costs of wafers and materials, or shortages in wafers and materials, could increase our costs of operations and our business could be harmed. Raw material price fluctuations can increase the cost of our products, impact our ability to meet end customer commitments, and may adversely affect our results of operations.
We are dependent on a limited number of distributors and end customers. The loss of, or a significant disruption in, the relationships with any of these distributors or end customers could significantly reduce our revenue and adversely impact our operating results. In addition, if we are unable to expand or further diversify our end customer base, our business, financial condition, and results of operations could suffer.
Because we do not have long-term purchase commitments with our end customers, orders may be cancelled, reduced, or rescheduled with little or no notice, which in turn exposes us to inventory risk, and may cause our business, financial results and future prospects to be harmed.
The complexity of our products could result in unforeseen delays or expenses from undetected defects, errors or bugs in hardware or software which could reduce the market adoption of our products, damage our reputation with current or prospective end customers and adversely affect our operating costs.
We may experience difficulties in transitioning to new wafer fabrication process technologies or in achieving higher levels of design integration, which may result in reduced manufacturing yields, delays in product deliveries and increased costs.
From time to time, we may rely on strategic partnerships, joint ventures and alliances for manufacturing and research and development. However, we may not control these partnerships and joint ventures, and actions taken by any of our partners or the termination of these partnerships or joint ventures could adversely affect our business.
We may pursue mergers, acquisitions, investments and joint ventures, which could divert our management’s attention or otherwise disrupt our operations and adversely affect our results of operations.






Tax-Related Risks
We could be subject to domestic or international changes in tax laws, tax rates or the adoption of new tax legislation, or we could otherwise have exposure to additional tax liabilities, which could adversely affect our business, results of operations, financial condition or future profitability.
Navitas Semiconductor Limited, our principal operating subsidiary (“Legacy Navitas”), is a tax resident of, and is subject to tax in, both the United States and Ireland. While we intend to pursue relief from double taxation under the double tax treaty between the United States and Ireland, there can be no assurance that such efforts will be successful. Accordingly, the status of Legacy Navitas as a tax resident in the U.S. and Ireland may result in an increase in our cash tax obligations and effective tax rate, which increase may be material.
Any adjustment to the purchase price of the assets that were transferred pursuant to the restructuring of Legacy Navitas in 2020 could adversely impact our tax position.
As a result of the plans to expand our business operations, including to jurisdictions in which tax laws may not be favorable, our obligations may change or fluctuate, become significantly more complex or become subject to greater risk of examination by taxing authorities, any of which could adversely affect our after-tax profitability and financial results.

Risks Related to Intellectual Property
We may not be able to adequately protect our intellectual property rights. If we fail to adequately enforce or defend our intellectual property rights, our business may be harmed.
We may not be able to obtain additional patents and the legal protection afforded by any additional patents may not adequately cover the full scope of our business or permit us to gain or keep competitive advantage.
If we infringe or misappropriate, or are accused of infringing or misappropriating, the intellectual property rights of third parties, we may incur substantial costs or be prevented from being able to commercialize new products.
Our ability to design and introduce new products in a timely manner is dependent upon third-party intellectual property, including third-party and “open source” software.

Risks Related to Owning Our Common Stock
Concentration of ownership among existing executive officers, directors and their affiliates, including the investment funds they represent, may prevent new investors from influencing significant corporate decisions.
If securities analysts do not publish research or reports about our business or if they downgrade our stock or our sector, our stock price and trading volume could decline.
The issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans or otherwise by us could dilute the ownership and voting power of our stockholders.
Our management has limited public company experience. The obligations associated with being a public company involve significant expenses and require significant resources and management attention, which may divert from our business operations and if we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud.
We have identified material weaknesses in our internal control over financial reporting. If we are unable to remedy these material weaknesses, or if we fail to establish and maintain effective internal controls, we may be unable to produce timely and accurate financial statements, and we may conclude that our internal control over financial reporting is not effective, which could adversely impact our investors’ confidence and our stock price.
We may issue a substantial number of additional shares under our employee equity incentive plans.






TABLE OF CONTENTS
Page
Part I - Financial Information
Item 1.
Item 2.
Item 4.
Item 1.
Item 1A.
Item 5.
4

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

(In thousands, except shares and par value)March 31, 2023December 31, 2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$100,823 $110,337 
Accounts receivable, net (less allowance of $300 and $0)
7,423 9,127 
Inventories18,873 19,061 
Prepaid expenses and other current assets2,880 3,623 
Total current assets129,999 142,148 
PROPERTY AND EQUIPMENT, net6,840 6,532 
OPERATING LEASE RIGHT OF USE ASSETS6,537 6,381 
INTANGIBLE ASSETS, net105,569 105,620 
GOODWILL161,442 161,527 
OTHER ASSETS5,581 3,054 
Total assets$415,968 $425,262 
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and other accrued expenses$13,610 $14,653 
Accrued compensation expenses7,711 3,907 
Operating lease liabilities, current1,477 1,305 
Other liabilities674 486 
Total current liabilities23,472 20,351 
OPERATING LEASE LIABILITIES NONCURRENT5,248 5,263 
EARNOUT LIABILITY40,816 13,064 
DEFERRED TAX LIABILITIES1,829 1,824 
Total liabilities71,365 40,502 
COMMITMENTS AND CONTINGENCIES (Note 15)
STOCKHOLDERS’ EQUITY:
    Common stock, $0.0001 par value, 750,000,000 shares authorized as of both March 31, 2023 and December 31, 2022, and 160,943,107 and 153,628,838 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively
18 18 
Additional paid-in capital561,193 535,875 
Accumulated other comprehensive loss(7)(7)
Accumulated deficit(216,601)(154,754)
Total stockholders’ equity of Navitas Semiconductor Corporation344,603 381,132 
Noncontrolling interest 3,628 
Total stockholders’ equity344,603 384,760 
Total liabilities and stockholders’ equity$415,968 $425,262 
The accompanying condensed notes are an integral part of these condensed consolidated financial statements
5

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

Three Months Ended
March 31,
(In thousands, except per share amounts)20232022
NET REVENUES (including $0 and $613 of related party revenues)
$13,358 $6,740 
COST OF REVENUES (exclusive of amortization of intangible assets included below)7,873 3,777 
OPERATING EXPENSES:
Research and development17,394 13,325 
Selling, general and administrative19,058 24,544 
Amortization of intangible assets4,499 88 
Total operating expenses40,951 37,957 
LOSS FROM OPERATIONS(35,466)(34,994)
OTHER INCOME (EXPENSE), net:
Interest income (expense), net 903 (24)
Gain from change in fair value of warrants 51,763 
Gain (loss) from change in fair value of earnout liabilities(27,752)63,406 
Other income (expense)11 (356)
              Total other income (expense), net(26,838)114,789 
INCOME (LOSS) BEFORE INCOME TAXES(62,304)79,795 
INCOME TAX PROVISION61 3 
NET INCOME (LOSS)(62,365)79,792 
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS(518) 
NET INCOME (LOSS) ATTRIBUTABLE TO CONTROLLING INTERESTS$(61,847)$79,792 
NET INCOME (LOSS) PER COMMON SHARE:
Basic net income (loss) per share attributable to common stockholders$(0.39)$0.67 
Diluted net income (loss) per share attributable to common stockholders$(0.39)$0.61 
WEIGHTED AVERAGE COMMON SHARES USED IN NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS:
Basic common shares156,792 119,542 
Diluted common shares156,792 131,149 
The accompanying condensed notes are an integral part of these condensed consolidated financial statements.
6

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(unaudited)

Three Months Ended March 31,
(In thousands)20232022
NET INCOME (LOSS)$(62,365)$79,792 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net of tax (60)
Total other comprehensive income (loss) (60)
COMPREHENSIVE INCOME (LOSS) INCLUDING NONCONTROLLING INTEREST(62,365)79,732 
COMPREHENSIVE INCOME ATTRIBUTABLE TO NONCONTROLLING INTEREST(518) 
TOTAL COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CONTROLLING INTEREST$(61,847)$79,732 
The accompanying condensed notes are an integral part of these condensed consolidated financial statements.
7

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(unaudited)

Stockholder's equity
THREE MONTHS ENDED MARCH 31, 2023Common stockAdditional
paid in
capital
Accumulated
deficit
Accumulated
comprehensive
income (loss)
Noncontrolling interestTotal
SharesAmount
BALANCE AT DECEMBER 31, 2022153,629 $18 $535,875 $(154,754)$(7)3,628 $384,760 
Issuance of common stock under employee stock option and stock award plans3,082 — 2,925 — — — $2,925 
Shares issued in connection with buyout agreement (see Note 18)4,232 — 7,509 — — (3,110)$4,399 
Stock-based compensation expense related to employee and non-employee stock awards— — 14,884 — — — $14,884 
Net loss— — — (61,847)— (518)(62,365)
BALANCE AT MARCH 31, 2023160,943 $18 $561,193 $(216,601)$(7)$ $344,603 

Stockholder's equity
THREE MONTHS ENDED MARCH 31, 2022Common stockAdditional
paid in
capital
Accumulated
deficit
Accumulated
comprehensive
income (loss)
Noncontrolling interestTotal
SharesAmount
BALANCE AT DECEMBER 31, 2021117,751 $15 $294,190 $(228,667)$(2) $65,536 
Issuance of common stock under employee stock option and stock award plans2,459 — 1,305 — — — $1,305 
Repurchase of common stock(67)— (550)— — — $(550)
Exercise of warrants3,318 — 29,641 — — — $29,641 
Stock-based compensation expense related to employee and non-employee stock awards— — 24,072 — — — $24,072 
Foreign currency translation adjustment— — — — (60)— $(60)
Net income— — — 79,792 — — 79,792 
BALANCE AT MARCH 31, 2022123,461 $15 $348,658 $(148,875)$(62)$ $199,736 

The accompanying condensed notes are an integral part of these condensed consolidated financial statements.
8

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(unaudited)
Three Months Ended March 31,
(In thousands)20232022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)$(62,365)$79,792 
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation506 125 
Amortization of intangible assets4,536 88 
Non-cash lease expense512 243 
Other85 (357)
Stock-based compensation expense17,161 25,326 
Amortization of debt discount and issuance costs 3 
Gain from change in fair value of warrants (51,763)
(Gain) loss from change in fair value of earnout liability27,752 (63,406)
Deferred income taxes5  
Change in operating assets and liabilities:
Accounts receivable1,704 (1,358)
Inventory188 (1,152)
Prepaid expenses and other current assets743 (109)
Other assets(1,612)1,391 
Accounts payable, accrued compensation and other expenses3,376 817 
Operating lease liability(511)(241)
Net cash used in operating activities(7,920)(10,601)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment purchases(1,000) 
Investment in Joint Venture (2,704)
Purchases of property and equipment(815)(294)
Receipts on notes receivable 6 
Net cash used in investing activities(1,815)(2,992)
CASH FLOWS FROM FINANCING ACTIVITIES:
Redemption of warrants (38)
Repurchase of common stock (550)
Proceeds from issuance of common stock in connection stock option exercises221 526 
Principal payments on long-term debt (800)
Net cash provided by (used in) financing activities221 (862)
NET DECREASE IN CASH AND CASH EQUIVALENTS(9,514)(14,455)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD110,337 268,252 
CASH AND CASH EQUIVALENTS AT END OF PERIOD$100,823 $253,797 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes$10 $23 
Cash paid for interest$ $67 
Shares issued in connection with buyout agreement (see Note 18)$22,400 $ 
Capital expenditures in accounts payable$228 $ 
    The accompanying condensed notes are an integral part of these condensed consolidated financial statements.

9

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)




1. ORGANIZATION AND BASIS OF PRESENTATION
On May 6, 2021, Navitas Semiconductor Limited, a private company limited by shares organized under the laws of Ireland (“Navitas Ireland”) and domesticated in the State of Delaware as Navitas Semiconductor Ireland, LLC, a Delaware limited liability company (“Navitas Delaware” and, together with Navitas Ireland, “Legacy Navitas”), entered into a business combination agreement and plan of reorganization (the “Business Combination Agreement” or “BCA”) with Live Oak Acquisition Corp. II, a Delaware corporation (“Live Oak”). Pursuant to the BCA, among other transactions consummated on October 19, 2021 (collectively, the “Business Combination”), Live Oak acquired all of the capital stock of Navitas Ireland (other than the Navitas Ireland Restricted Shares, as defined below) by means of a tender offer, and a wholly owned subsidiary of Live Oak merged with and into Navitas Delaware, with Navitas Delaware surviving the merger. As a result, Legacy Navitas became a wholly owned subsidiary of Live Oak effective October 19, 2021. At the closing of the Business Combination, Live Oak changed its name to Navitas Semiconductor Corporation (“Navitas”).
References to the “Company” in these financial statements refer to Legacy Navitas and its predecessors before the consummation of the Business Combination, or to Navitas Semiconductor Corporation after the Business Combination, as the context suggests.
The Company designs, develops and markets next-generation power semiconductors including gallium nitride (“GaN”) power integrated circuits (“ICs”), silicon carbide (“SiC”) and associated high-speed silicon system controllers, and digital isolators used in power conversion and charging. Power supplies incorporating the Company’s products may be used in a wide variety of electronics products including fast chargers for mobile phones and laptops, consumer electronics, data centers, solar inverters and electric vehicles, among numerous other applications. The Company’s products provide superior efficiency, performance, size, cost and sustainability relative to existing silicon technology. The Company presently operates as a product design house that contracts the manufacturing of its chips and packaging to partner suppliers. Navitas maintains its operations around the world, including the United States, Ireland, Germany, Italy, Belgium, China, Taiwan, Thailand and the Philippines, with principal executive offices in Torrance, California.
Reorganization
Navitas Semiconductor USA, Inc. (f/k/a Navitas Semiconductor, Inc., “Navitas U.S.”) was incorporated in the State of Delaware on October 25, 2013. In 2020 Navitas U.S. initiated a restructuring to streamline its worldwide legal entity structure and more efficiently align its business operations (the “Restructuring”). The Restructuring introduced wholly owned subsidiaries in Hong Kong and China as well as the addition of Legacy Navitas, an entity registered in Ireland and the U.S., as the parent of Navitas U.S. and the other Navitas subsidiaries. In connection with the Restructuring, effective September 1, 2020, Legacy Navitas acquired certain intellectual property and other intangible assets from Navitas U.S. and, after the Restructuring, contracts directly with customers. The transfer of intellectual property and other intangible assets by Navitas U.S. to Legacy Navitas in connection with the Restructuring was among entities within the same consolidated group and, as a result, did not result in any gain or loss to the Company. Legacy Navitas is treated as a corporation for U.S. federal income tax purposes and is a tax resident in both Ireland and the United States. See Note 14, Provision for Income Taxes, for more information.
Acquisitions
In June 2022, the Company acquired VDDTECH srl, a Belgian private company, for approximately $1.9 million in cash and stock, and in August 2022 the Company acquired GeneSiC for approximately $246.2 million in cash and stock. See Note 17, Business Combinations, for more information.
In January 2023, the Company announced an agreement to acquire the remaining minority interest in its silicon control IC joint venture from Halo Microelectronics International Corporation for a purchase price of $22.4 million in Navitas stock. The transaction was completed in February 2023. See Note 18, Noncontrolling Interest, for more information

10

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


Basis of Consolidation
The accompanying condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
The results of operations for the three months ended March 31, 2023 shown in this report are not necessarily indicative of results to be expected for the full year ending December 31, 2023. In the opinion of the Company’s management, the information contained herein reflects all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the Company’s results of operations, financial position, cash flows and stockholders’ equity (deficit). Certain footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (“SEC”) rules and regulations relating to interim financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with consolidated financial statements and notes thereto contained in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on April 3, 2023. Except as further described below, there have been no significant changes in the Company’s accounting policies from those disclosed in its Form 10-K filed with the SEC on April 3, 2023.
The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material intercompany transactions between and among the Company and its consolidated subsidiaries have been eliminated in consolidation. The Company’s net income (loss) excluded income (loss) attributable to the noncontrolling interests. The consolidated financial statements include the accounts of Elevation Semiconductor Inc. (the “Joint Venture”), an entity in which the Company had a controlling interest since August 19, 2022 (see Note 18, Noncontrolling Interest). During the first quarter of fiscal year 2023 the Company acquired the remaining noncontrolling interest in the Joint Venture. The transaction was completed on February 13, 2023. As Navitas already had a controlling interest, financial results from the Joint Venture have already been reflected in Navitas’ historical financial statements.
The condensed consolidated financial statements include the accounts of the Company, its wholly owned or majority-owned subsidiaries and entities in which the Company is deemed to have a direct or indirect controlling financial interest based on either a variable interest model or voting interest model. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
On an ongoing basis, management evaluates the assumptions used in making estimates, including those related to (i) the collectability of accounts receivable; (ii) write-down for excess and obsolete inventory; (iii) warranty obligations; (iv) the value assigned to and estimated useful lives of long-lived assets; (v) the realization of tax assets and estimates of tax liabilities and tax reserves; (vi) recoverability of intangible assets; (vii) the computation of share-based compensation; (viii) accrued compensation and other expenses; and (ix) the recognition of revenue. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company engages third-party valuation specialists to assist with estimates related to the valuation of intangible assets, stock options, restricted common stock awards,earnout shares and warrants. Such estimates often require the selection of appropriate valuation methodologies and models, and significant judgment in evaluating ranges of assumptions and financial inputs. Actual results could differ from those estimates.


11

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


2. SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS

Business Combinations

We account for business combinations using the acquisition method of accounting, in accordance with Accounting Standards Codification (“ASC”) 805,Business Combinations”. The acquisition method requires identifiable assets acquired and liabilities assumed to be recognized and measured at fair value on the acquisition date, which is the date that the acquirer obtains control of the acquired business. The amount by which the fair value of consideration transferred exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill.
The determination of estimated fair value requires us to make significant estimates and assumptions. These fair value determinations require judgment and involve the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, and asset lives, among other items. As a result, we may record adjustments to the fair values of assets acquired and liabilities assumed within the measurement period (up to one year from the acquisition date) with the corresponding offset to goodwill.
Transaction costs associated with business combinations are expensed as they are incurred.

Valuation of Contingent Consideration Resulting from a Business Combination
In connection with certain acquisitions, we may be required to pay future consideration that is contingent upon the achievement of specified milestone events. We record contingent consideration resulting from a business combination at its fair value on the acquisition date. Each quarter thereafter, we revalue these obligations and record increases or decreases in their fair value within our Condensed Consolidated Statements of Operations until such time as the specified milestone achievement period is complete.
Increases or decreases in fair value of the contingent consideration liabilities can result from updates to assumptions such as the expected timing or probability of achieving the specified milestones. Significant judgment is employed in determining these assumptions as of the acquisition date and for each subsequent period. Updates to assumptions could have a significant impact on our results of operations in any given period. Actual results may differ from estimates.

Recently Adopted Accounting Standards

Credit Losses
In June 2016, the Financial Accounting Standards Board (“FASB”) amended guidance related to impairment of financial instruments as part of ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which replaced the incurred loss impairment methodology with an expected credit loss model for which a company recognizes an allowance based on the estimate of expected credit loss. This ASU requires entities to measure the impairment of certain financial instruments, including accounts receivable, based on expected losses rather than incurred losses. For companies that qualify under the emerging growth company exemptions, this ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted, and is effective for the Company beginning in 2023. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.
We pool financial assets based on their risk characteristics, which include class of customer, geographic location of the customer, contractual life of the financial asset, and age of the open receivable balance. The allowance for credit losses pool is estimated based on historical credit loss rates adjusted for management’s reasonable and supportable expectations of future economic conditions, which consider macroeconomic, industry and market trends that could impact future credit loss rates. Additions to the allowance are charged to general and administrative expenses in the consolidated statements of operations. Accounts receivable are written off against the allowance when the probability of collection of an account balance is deemed remote.
12

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


3. INVENTORY
Inventory consists of the following (in thousands):
 March 31, 2023December 31, 2022
Raw materials
$3,551 $4,314 
Work-in-process
11,609 9,166 
Finished goods
3,713 5,581 
Total
$18,873 $19,061 
4. PROPERTY AND EQUIPMENT, NET
Property and equipment, net consist of the following (in thousands):
March 31, 2023December 31, 2022
Furniture and fixtures$202 $215 
Computers and other equipment8,064 7,251 
Leasehold improvements2,045 2,054 
Construction in Progress71  
10,382 9,520 
Accumulated depreciation(3,542)(2,988)
Total$6,840 $6,532 
For the three months ended March 31, 2023 and 2022, depreciation expense was $0.5 million and $0.1 million, respectively, and was determined using the straight-line method over the following estimated useful lives:
Furniture and fixtures
3 — 7 years
Computers and other equipment
2 — 5 years
Leasehold improvements
2 — 5 years
5. FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES
The accounting guidance on fair value measurements clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices for identical assets in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.
The short-term nature of the Company’s cash and cash equivalents, accounts receivable, debt and current liabilities causes each of their carrying values to approximate fair value for all periods presented. Cash equivalents classified as Level 1 instruments were not material as of March 31, 2023 and December 31, 2022.

13

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


The following table presents the Company’s fair value hierarchy for financial liabilities as of March 31, 2023 (in thousands):

Level 1Level 2Level 3Total
Liabilities:
Earnout liability$ $ $40,816 $40,816 
Total$ $ $40,816 $40,816 
The following table presents the Company’s fair value hierarchy for financial liabilities as of December 31, 2022 (in thousands):

Level 1Level 2Level 3Total
Liabilities:
Earnout liability$ $ $13,064 $13,064 
Total$ $ $13,064 $13,064 
The following table provides a reconciliation between the beginning and ending balances of items measured at fair value on a recurring basis that used significant unobservable inputs (Level 3) (in thousands):

Fair Value Measurements Using Significant Unobservable Inputs
Balance at December 31, 2022$13,064 
Fair value adjustment27,752 
Balance at March 31, 2023$40,816 
The Company did not transfer any investments between Level 1 and Level 2 of the fair value hierarchy during the three months ended March 31, 2023.

6. GOODWILL AND INTANGIBLES

Goodwill represents the excess of the consideration transferred over the estimated fair value of assets acquired and liabilities assumed in a business combination. Intangible assets are measured at their respective fair values as of the acquisition date and may be subject to adjustment within the measurement period, which may be up to one year from the acquisition date. Goodwill and indefinite-lived intangible assets are tested for impairment annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the assets are impaired.
The following table presents the changes in the Company’s goodwill balance (in thousands):

Goodwill
Balance at December 31, 2022$161,527 
Purchase price adjustment(85)
Balance at March 31, 2023$161,442 

14

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


Refer to Note 17, Business Combinations, for further details.





.

The following table presents the Company’s intangible asset balance by asset class as of March 31, 2023 (in thousands):

Intangible AssetCostAccumulated AmortizationNet Book ValueAmortization MethodUseful Life
Trade Names$900 $(281)$619 Straight line2 years
Developed Technology53,500 (7,672)45,828 Straight line
4-10 years
In-process R&D1,177 — 1,177 IndefiniteN/A
Patents33,900 (1,412)32,488 Straight line
5-15 years
Customer Relationships24,300 (1,519)22,781 Straight line10 years
Non-Competition Agreements1,900 (238)1,662 Straight line5 years
Other1,926 (912)1,014 Straight line5 years
Total$117,603 $(12,034)$105,569 

The following table presents the changes in the Company’s intangible asset balance (in thousands):
                
Intangible Assets, net
Balance at December 31, 2022$105,620 
Additions to intangible assets4,485 
Amortization expense(4,536)
Balance at March 31, 2023$105,569 

The amortization expense was $4.5 million and $0.1 million for the three months ended March 31, 2023 and 2022, respectively.
There were no impairment charges during the three months ended March 31, 2023 and 2022.

7. DEBT OBLIGATIONS
On April 29, 2020, the Company entered into a loan and security agreement with a new bank (the “Term Loan”), which provided for term advances up to $8.0 million. As of March 31, 2023, this loan had been paid in full.
In connection with execution of the Term Loan, the Company issued warrants to the bank (see Note 10. Warrant Liability). The fair value of the warrants at the date of issuance was not material and was recorded as debt discount, subject to amortization using the effective interest rate method over the term of the loan. All warrants were redeemed by December 31, 2022, and amortization of debt discount and issuance costs was not significant either of the three months ended March 31, 2023 or 2022.
15

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)




8. LEASES:
The Company has entered into operating leases primarily for commercial buildings. These leases have terms which range from 0.5 to 5.7 years. As of March 31, 2023 no operating lease agreements contain economic penalties for the Company to extend the lease, and it is not reasonably certain the Company will exercise these extension options. Additionally, these operating lease agreements do not contain material residual value guarantees or material restrictive covenants. As of March 31, 2023 all leases recorded on the Company’s consolidated balance sheets were operating leases.
Upon adoption of ASC 842 on January 1, 2022, the Company recorded operating lease assets of $1.6 million and lease liabilities of $1.7 million in the Company’s consolidated balance sheets. The adoption of this standard did not have a material impact on retained earnings, the consolidated statements of operations, or cash flows. The Company obtained $0.6 million in additional right-of-use assets in exchange for lease obligations during the three months ended March 31, 2023. The Company has made the accounting policy election to use certain ongoing practical expedients made available by ASC 842 to: (i) not separate lease components from nonlease components for real estate; and (ii) exclude leases with an initial term of 12 months or less (“short-term” leases) from the consolidated balance sheets and will recognize related lease payments in the consolidated statements of operations on a straight-line basis over the lease term. For leases that do not have a readily determinable implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at the lease commencement date to determine the present value of lease payments.
Rent expense, including short-term lease cost, was $0.5 million and $0.4 million for the three months ended March 31, 2023 and 2022, respectively. In addition to rent payments, the Company’s leases include real estate taxes, common area maintenance, utilities, and management fees, which are not fixed. The Company accounts for these costs as variable payments and does not include such costs as a lease component. Total variable expense was not material for the three months ended March 31, 2023 and 2022. There were no leases that had not yet commenced as of March 31, 2023, that will create significant additional rights and obligations for the Company.
Information related to the Company right-of-use assets and related operating lease liabilities were as follows (in thousands):

Three Months Ended March 31,
20232022
Cash paid for operating lease liabilities$454 $261 
Operating lease cost$512 $263 
Non-cash right-of-use assets obtained in exchange for new operating lease obligations$590 $1,391 
Weighted-average remaining lease term4.96 years2.06 years
Weight-average discount rate
4.25% - 7.75%
4.25 %


Right-of-use assets and lease liabilities consisted of the following (in thousands):
16

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


March 31, 2023December 31, 2022
Assets:
Operating lease right-of-use assets$6,537 $6,381 
Liabilities:
Operating lease liabilities - current1,477 1,305 
Operating lease liabilities - noncurrent5,248 5,263 
Total lease liabilities$6,725 $6,568 

Maturities of lease liabilities are as follows (in thousands):
Remainder of fiscal year 2023$1,422 
Fiscal year 20241,532 
Fiscal year 20251,239 
Fiscal year 20261,183 
Fiscal year 20271,218 
Thereafter1,125 
$7,719 
Less imputed interest994 
Total lease liabilities$6,725 


9. SHARE BASED COMPENSATION:
 Equity Incentive Plans
The Navitas Semiconductor Limited 2020 Equity Incentive Plan, initially adopted by the Company’s board of directors on August 5, 2020 as an amendment and restatement of the 2013 Equity Incentive Plan (“2013 Plan”), was amended and restated at the Closing of the Business Combination as the Amended and Restated Navitas Semiconductor Limited 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit (“RSU”) awards, stock appreciation rights, and other stock awards to employees, directors and consultants. Pursuant to the 2020 Plan, the exercise price for incentive stock options and non-statutory stock options is generally at least 100% of the fair market value of the underlying shares on the date of grant. Options generally vest over 48 months measured from the date of grant. Options generally expire no later than ten years after the date of grant, subject to earlier termination upon an optionee’s cessation of employment or service.
Under the terms of the 2020 Plan, the Company is authorized to issue 18,899,285 shares of common stock pursuant to awards under the 2020 Plan. As of October 19, 2021, the Company had issued an aggregate of 11,276,706 stock options and non-statutory options to its employees and consultants and 4,525,344 RSUs to employees, directors and consultants under the 2020 Plan. No awards have or will be issued under the 2020 Plan after October 19, 2021. Shares of Common Stock subject to awards under the 2020 Plan that are forfeited, expire or lapse after October 19, 2021 will become authorized for issuance pursuant to awards under the 2021 Plan (as defined below).
The Navitas Semiconductor Corporation 2021 Equity Incentive Plan (the “2021 Plan”) was adopted by the Company’s board of directors on August 17, 2021 and adopted and approved by the Company’s stockholders on October 12, 2021. Under the terms of the 2021 Plan, the Company is authorized to issue, pursuant to awards granted under the 2021 Plan, (a) up to 16,334,527 shares of Common Stock; plus (b) up to 15,802,050 shares of Common Stock subject to awards under the 2020 Plan that are forfeited, expire or lapse after October 19, 2021; plus (c) an annual increase, effective as of the first day of each fiscal year up to and including January 1, 2031, equal to the lesser of (i) 4% of the
17

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


number of shares of Common Stock outstanding as of the conclusion of the Company’s immediately preceding fiscal year, or (ii) such amount, if any, as the board of directors may determine. As of March 31, 2023 the Company has issued 9,750,000 non-statutory stock options under the 2021 Plan.

Stock-Based Compensation
At the Closing of the Business Combination on October 19, 2021, Legacy Navitas’ outstanding vested and unvested share-based compensation awards (as such terms are defined below) were converted into equity, RSUs or options in the Company at a ratio of 1.0944 to 1 share (the “Exchange Ratio”). Share and per share information below has been converted from historical disclosures based on the Exchange Ratio.
The Company recognizes the fair value of stock-based compensation in its financial statements over the requisite service period of the individual grants, which generally equals a four-year vesting period, except for long-term incentive performance stock options (“LTIP Options”) discussed below. The Company uses estimates of volatility, expected term, risk-free interest rate and dividend yield in determining the fair value of these awards and the amount of compensation expense to recognize. The Company uses the straight-line method to amortize stock awards granted over the requisite service period of the award, which may be explicit or derived, unless market or performance conditions result in a graded attribution.
The following table summarizes the stock-based compensation expense recognized for the three months ended March 31, 2023 and 2022:

Three Months Ended March 31,
20232022
Research and development$7,177 $7,494 
Selling, general and administrative9,983 17,832 
Total stock-based compensation expense$17,160 $25,326 

Stock Options
Generally, stock options granted under the Plans have terms of ten years and vest in 1/4th increments on the anniversary of the vesting commencement date and in 1/48th increments monthly thereafter. Stock options with performance vesting conditions begin to vest upon achievement of the performance condition. Expense is recognized beginning in the period in which performance is considered probable.
The fair value of incentive stock options and non-statutory stock options issued was estimated using the Black-Scholes model. The Company did not grant any stock option awards during either the three months ended March 31, 2023 or 2022.
A summary of stock options outstanding, excluding LTIP Options as of March 31, 2023, and activity during the three months then ended, is presented below:

Stock OptionsShares
(In thousands)
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term
(In years)
Outstanding at December 31, 20226,775 $0.59 6.20
Granted  — 
Exercised(512)0.44 — 
Forfeited or expired(136)1.06 — 
Cancelled  — 
Outstanding at March 31, 20236,127 $0.61 6.20
Vested and Exercisable at March 31, 20235,015 $0.51 5.90
18

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


During both the three months ended March 31, 2023 and 2022, the Company recognized $0.1 million of stock-based compensation expense for the vesting of outstanding stock options, excluding $2.5 million and $1.4 million related to the LTIP Options described below. At March 31, 2023, unrecognized compensation cost related to unvested awards totaled $0.5 million. The weighted-average period over which this remaining compensation cost will be recognized is 1.2 years.

Long-term Incentive Plan Stock Options
The Company awarded a total of 6,500,000 LTIP Options to certain members of senior management on December 29, 2021 pursuant to the 2021 Plan. These non-statutory options are intended to be the only equity awards for the recipients over the duration of the performance period. The options vest in increments subject to achieving certain performance conditions, including ten share price hurdles ranging from $15 to $60 per share, coupled with revenue and EBITDA targets, measured over a seven-year performance period and expire on the tenth anniversary of the grant date. The options have an exercise price of $15.51 per share and the average fair value on the grant date was $8.13 based on the Black-Scholes model and a Monte Carlo simulation incorporating 500,000 scenarios. The weighted average contractual period remaining is 8.8 years. The Company utilized the services of a professional valuation firm to finalize these assumptions during the fiscal year ended December 31, 2022. The valuation model utilized the following assumptions:

Risk-free interest rates1.47 %
Expected volatility rates58 %
Expected dividend yield 
Cost of equity (for derived service period)9.96 %
Weighted-average grant date fair value of options$8.13 

In connection with LTIP Options granted in 2021, the Company recognized $2.2 million and $1.4 million of stock-based compensation expense for the three months ended March 31, 2023 and 2022, respectively. The unrecognized compensation expense related to these LTIP Options is $51.6 million as of March 31, 2023, and compensation expense will be recognized over 3.2 years.
The Company awarded a total of 3,250,000 LTIP Options to a member of senior management on August 15, 2022 pursuant to the 2021 Plan. The options vest in increments subject to achieving certain market and performance conditions, including ten share price hurdles ranging from $15 to $60 per share, coupled with revenue and EBITDA targets, measured over a seven year performance period and expire on the tenth anniversary of the grant date. The options have an exercise price of $10.00 per share and the average fair value on the grant date was $2.51. The weighted average contractual period remaining is 9.4 years. The Black-Scholes model and a Monte Carlo simulation incorporated 100,000 scenarios. The valuation model utilized the following assumptions:

Risk-free interest rates2.82 %
Expected volatility rates63 %
Expected dividend yield 
Cost of equity (for derived service period)14.64 %
Weighted-average grant date fair value of options$2.51 
In connection with LTIP Options granted in 2022, the Company recognized $0.3 million of stock-based compensation expense for the three months ended March 31, 2023. The unrecognized compensation expense related to the LTIP Options is $8.7 million as of March 31, 2023, and compensation expense will be recognized over 3.8 years.

Restricted Stock Units
On August 25, 2021, the Company granted an aggregate of 4,135,000 Legacy Navitas RSUs under the 2020 Plan to certain members of senior management pursuant to restricted stock unit agreements (collectively, the “RSU Agreements”). Each RSU represents the right to receive one share of common stock of the Company, subject to the vesting and other
19

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


terms and conditions set forth in the RSU Agreements and the Plan. 3,500,000 of these RSU awards vest in three equal installments over a three-year period subject to the occurrence of an IPO (which includes the Business Combination) and certain valuation targets, subject to an accelerated vesting schedule based on the satisfaction of certain stock price targets. Up to 500,000 of these RSUs were eligible to vest on the six-month anniversary of the grant date, subject to the occurrence of an IPO (which included the Business Combination) and certain valuation targets. 52,500 RSUs vested upon the occurrence of the Business Combination, while the remaining 82,500 RSUs vest as specified by an RSU Agreement over a period of approximately three years. As of October 19, 2021, the IPO performance condition had been met due to the Business Combination.
Additionally, the Company regularly grants RSUs to employees as a component of their compensation. A summary of RSUs outstanding as of March 31, 2023, and activity during the three months then ended, is presented below:

Shares
(In thousands)
Weighted-Average Grant Date Fair Value Per Share
Outstanding at December 31, 202211,606 $5.93 
   Granted5,392 6.15 
   Vested(1,707)7.46 
   Forfeited(67)6.62 
Outstanding at March 31, 202315,224 $6.30 

During the three months ended March 31, 2023 and 2022, the Company recognized $7.1 million and $16.2 million of stock-based compensation expense for the vesting of RSUs, respectively. As of March 31, 2023, unrecognized compensation cost related to unvested RSU awards totaled $90.2 million. The weighted-average period over which this remaining compensation cost is expected be recognized is 2.8 years.
The Company implemented a yearly a stock-based bonus plan in 2021 which settles by issuing a variable number of fully-vested restricted stock units to employees in the first quarter of the following fiscal year. The $2.3 million accrued as of March 31, 2023 reflects eligible employees included the Company’s 2023 annual bonus plan and amounts expected to be settled during the first quarter of 2024. The $2.8 million accrued as of December 31, 2022 was for the Company’s 2022 annual bonus plan and a balance of $0.1 million is accrued as of March 31, 2023.
Other Share Awards
In connection with the acquisition of the remaining minority interest of a silicon control IC joint venture, as described in Note 18, the Company issued 841,729 fully vested shares to certain former employees of the joint venture with a grant date fair value totaling $4.5 million. Such amount has been recognized as stock-based compensation expense during the three months ended March 31, 2023.
Unvested Earnout Shares
A portion of the earnout shares related to the Business Combination (discussed in Note 11 below) may be issued to individuals with unvested equity awards. While the payout of these shares requires achievement of share price targets based on the volume weighted average price of the Company’s common stock, the individuals are required to complete the remaining service period associated with these unvested equity awards to be eligible to receive the earnout shares. As a result, these unvested earn-out shares are equity-classified awards and have an aggregated grant date fair value of $19.1 million or $11.52 per share. During the three months ended March 31, 2023 and 2022 the Company recognized $0.3 million and $6.3 million, respectively, of stock-based compensation expense for the vesting of earnout shares. At March 31, 2023, there was no remaining compensation cost related to unvested earnout shares. Refer to Note 11, Earnout Liability.
20

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


10. WARRANT LIABILITY
In connection with the closing of the Business Combination, holders of Live Oak Class A ordinary shares automatically received Class A Common Stock of the Company, and holders of Live Oak warrants automatically received a total of 13,100,000 warrants of the Company with substantially identical terms (“the Warrants”). Accordingly, 8,433,333 Live Oak public warrants automatically converted into 8,433,333 warrants to purchase one share of the Company’s Class A Common Stock at $11.50 per share (the “Public Warrants”), and 4,666,667 private placement warrants held by the sponsor of the Business Combination and certain permitted transferees (“Private Placement Warrants”), each exercisable for one Class A ordinary share of Live Oak at $11.50 per share, automatically converted into warrants to purchase one share of the Company’s Class A Common Stock at $11.50 per share with substantially identical terms as the Public Warrants. On February 4, 2022, the Company gave notice that it would redeem all of the Warrants, as further described below.
The Warrants were exercisable only during the period commencing December 7, 2021 (12 months after the consummation of Live Oak’s initial public offering) and ending on the earlier of October 19, 2026 (five years after the Closing of the Business Combination) or, in the event of redemption, the corresponding redemption date. The Company had the right to redeem not less than all of the outstanding Public Warrants on 30 days’ notice, at a redemption price of $0.01 per Warrant, if the reported closing price of the Common Stock was at least $18.00 per share for any 20 of 30 trading days ending three business days before the notice of redemption, subject to certain other conditions. The Company also had the right to redeem not less than all of the outstanding Public Warrants on 30 days’ notice, at a redemption price of $0.10 per Warrant, if the reported closing price of the Common Stock was at least $10.00 per share for any 20 of 30 trading days ending three business days before the notice of redemption, subject to certain other conditions. If the Company elected to exercise the latter right to redeem the Public Warrants for $0.10 per Warrant, and the reported closing price of the Common Stock was less than $18.00 per share for any 20 of 30 trading days ending three business days before the notice of redemption, the Company was required by the terms of the Public Warrants to concurrently redeem the Private Placement Warrants on the same terms. In addition, in such event, holders of Warrants subject to redemption would have the right to exercise their Warrants on a “cashless” basis, whereby they would receive a fractional number of shares of Common Stock per Warrant exercised before the redemption date, based on the volume weighted average price of the Common Stock for the 10 trading days following notice of redemption (the “Redemption Fair Market Value”) and the time period between the redemption date and the original expiration date of the Warrants in the absence of redemption.
On February 4, 2022, the Company issued a notice of redemption that it would redeem, at 5:00 p.m. New York City time on March 7, 2022 (the “Redemption Date”), all of the Company’s outstanding Public Warrants and Private Placement Warrants to purchase shares of the Company’s Class A Common Stock that were governed by the Warrant Agreement, dated as of December 2, 2020 (the “Warrant Agreement”), between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agent”), at a redemption price of $0.10 per Warrant (the “Redemption Price”). On February 22, 2022, the Company issued a notice that the “Redemption Fair Market Value,” determined in accordance with the Warrant Agreement based on the volume weighted average price of the Common Stock for the 10 trading days immediately following the date on which notice of redemption was sent, was $10.33 and, accordingly, that holders exercising Warrants on a “cashless” basis before the Redemption Date would receive 0.261 shares of Common Stock per Warrant exercised. The Warrants were exercisable by their holders until immediately before 5:00 p.m. New York City time on the Redemption Date, either (i) on a cash basis, at an exercise price of $11.50 per share of Common Stock, or (ii) on a “cashless” basis in which the exercising holder would receive 0.261 shares of Common Stock per Warrant exercised. Between December 7, 2021 (the date the Warrants became exercisable) and the Redemption Date, an aggregate of 12,722,773 Warrants were exercised (including 17,785 on a cash basis and 12,704,988 on a “cashless” basis); an aggregate of 3,333,650 shares of Common Stock were issued upon exercise of the Warrants (including 17,785 shares in respect of cash exercises and 3,315,865 shares in respect of “cashless” exercises). A total of 377,187 Warrants remained outstanding and unexercised at the Redemption Date and were redeemed for an aggregate Redemption Price of $38. Prior to the Redemption Date, the warrants had an aggregate fair value of $81.4 million which resulted in a gain of $51.8 million due to the decrease in the fair value of the warrant liability in the three months ended March 31, 2022. There were no outstanding warrants as of March 31, 2023.

11. EARNOUT LIABILITY
Certain of the Company’s stockholders are entitled to receive up to 10,000,000 “earnout shares” of the Company’s Class A Common Stock if the earnout milestones are met. The earnout milestones represent three independent criteria, each of which entitles the eligible stockholders to 3,333,333 aggregate earn-out shares if the milestone is met. Each earnout milestone is considered met if at any time 150 days following the Business Combination and prior to October 19, 2026, the
volume weighted average price of the Company’s Class A Common Stock is greater than or equal to $12.50, $17.00 or $20.00, respectively, for any twenty trading days within any thirty trading day period, respectively. Further, the earnout milestones are also considered to be met if the Company undergoes a Sale. A Sale is defined as the occurrence of any of the following: (i) engaging in a “going private” transaction pursuant to Rule 13e-3 under the Exchange Act or otherwise ceasing to be subject to reporting obligations under Sections 13 or 15(d) of the Exchange Act; (ii) the Class A Common Stock ceases to be listed on a national security exchange, other than for the failure to satisfy minimum listing requirements under applicable stock exchange rules; or (iii) a change of ownership (including a merger or consolidation) or approval of a plan for complete liquidation or dissolution.
These earnout shares have been categorized into two components: (i) the “Vested Shares” – those associated with vested equity held by stockholders at the closing of the Business Combination that will be earned upon achievement of the earnout milestones and (ii) the “Unvested Shares” – those associated with unvested equity held by stockholders at the closing of the Business Combination that will be earned over the remaining service period with the Company on their Unvested Shares and upon achievement of the earnout milestones. The Vested Shares are classified as liabilities in the consolidated balance sheet and the Unvested Shares are equity-classified share-based compensation to be recognized over time (see Note 9, Share-based Compensation). The earnout liability was initially measured at fair value at the closing of the Business Combination and subsequently remeasured at the end of each reporting period. The change in fair value of the earn-out liability is recorded as part of Other income (expense), net in the consolidated statements of operations.
The estimated fair value of the earnout liability was determined using a Monte Carlo analysis of 20,000 simulations of the future path of the Company’s stock price over the earnout period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, and risk-free rate. The valuation model utilized the following assumptions:
March 31, 2023December 31, 2022
Risk-free interest rate
3.75 %4.13 %
Equity volatility rate
63.00 %65.00 %

At the closing of the Business Combination on October 19, 2021, the earnout liability had an initial fair value of $96.1 million, which was recorded as a long-term liability and a reduction to additional paid in capital in the consolidated balance sheets. As of March 31, 2023 and December 31, 2022, the earnout liability had a fair value of $40.4 million and $12.5 million, respectively which resulted in a loss in the fair value of the earnout liability of $27.9 million for the three months ended March 31, 2023 due to the increase in the fair value of the earnout liability.

GeneSiC Earnout Liability

In connection with the acquisition of GeneSiC as discussed in Note 17, the Company will pay additional contingent consideration of up to $25.0 million, in the form of cash earnout payments to the Sellers and certain employees of GeneSiC, conditioned on the achievement of substantial revenue and gross profit margin targets for the GeneSiC business over the four fiscal quarters beginning on October 1, 2022 and ending on September 30, 2023. The estimated fair value of the earnout liability was determined using a Monte Carlo analysis of 20,000 simulations assuming that GeneSiC’s revenue and gross profit margins follow a geometric Brownian motion over the earnout period. The valuation model utilized an assumption on the risk-free interest rate of 3.1% and equity volatility rate of 99.9%. As of March 31, 2023, the GeneSiC earnout probability is considered remote, and a liability of $0.4 million is recorded in earnout liability in the Company’s Condensed Consolidated Balance Sheets.
12. SIGNIFICANT CUSTOMERS AND CREDIT CONCENTRATIONS
Customer Concentration
A majority of the Company’s revenues are attributable to sales of the Company’s products to distributors of electronic components. These distributors sell the Company’s products to a range of end users, including OEMs and merchant power supply manufacturers
The following customers represented 10% or more of the Company’s net revenues for the three months ended March 31, 2023 and 2022:
21

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)



Three Months Ended March 31,
Customer20232022
Distributor A35 %*
Distributor B19 *
Distributor C17 31 %
Distributor D*39 
Distributor E*13 

*Total customer net revenues was less than 10% of total net revenues.

Revenues by Geographic Area
The Company considers the domicile of its end customers, rather than the distributors it sells to directly, to be the basis for attributing revenues from external customers to individual countries. Revenues for the three months ended March 31, 2023 and 2022 were attributable to end customers in the following countries or regions:
Three Months Ended March 31,
Country20232022
Europe*28 % 
China
57 58 %
United States
11 33 
Rest of Asia4 9 
All others  
Total
100 %100 %

*Impractical to disclose the revenue percentages by individual countries within Europe and therefore Europe is presented in total.

Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consisted principally of cash, cash equivalents and trade receivables. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. At times, such amounts may exceed federally insured limits. The Company has not experienced any losses on cash or cash equivalents held at financial institutions. The Company does not have any off-balance-sheet credit exposure related to its customers.
The following customers represented 10% or more of the Company’s accounts receivable.
CustomerMarch 31, 2023December 31, 2022
Distributor A32 %19 %
Distributor B19 25 
Distributor C11 *
*Total customer accounts receivable was less than 10% of total net accounts receivable.

Concentration of Supplier Risk
The Company currently relies on a single foundry to produce wafers for GaN ICs and a separate single foundry to produce wafers for SiC MOSFETs. Loss of the relationship with either of these suppliers could have a substantial negative
22

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


effect on the Company. Additionally, the Company relies on a limited number of third-party subcontractors and suppliers for testing, packaging and certain other tasks. Disruption or termination of supply sources or subcontractors, including due to pandemics or natural disasters such as an earthquake or other causes, could delay shipments and could have a material adverse effect on the Company. Although there are generally alternate sources for these materials and services, qualification of the alternate sources could cause delays sufficient to have a material adverse effect on the Company. A significant amount of the Company’s third-party subcontractors and suppliers, including the third-party foundry that supplies wafers for GaN ICs, are located in Taiwan. A significant amount of the Company’s assembly and test operations are conducted by third-party contractors in Taiwan and the Philippines.
23

NAVITAS SEMICONDUCTOR CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


13. NET INCOME (LOSS) PER SHARE:
Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average shares of common stock outstanding during the period. Diluted earnings per share are calculated by dividing net income (loss) by the weighted-average shares of common stock and dilutive common equivalent shares outstanding during the period. Dilutive common equivalent shares included in this calculation consist of dilutive shares issuable upon the assumed exercise of outstanding common stock options, the assumed vesting of outstanding restricted stock units and restricted stock awards, the assumed issuance of awards for contingently issuable performance-based awards, as computed using the treasury stock method. Performance-based restricted stock units and restricted stock awards are included in the number of shares used to calculate diluted earnings per share after evaluating the applicable performance criteria as of period end and under the assumption the end of the reporting period was the end of the contingency period, and the effect is dilutive. Restricted stock awards (but not restricted stock unit awards) are eligible to receive all dividends declared on the Company’s common shares during the vesting period; however, such dividends are not paid until the restrictions lapse. The Company has no plans to declare dividends.
A summary of the net income (loss) per share calculation is as follows (in thousands, except per share amounts): 
Three Months Ended March 31,
Numerator - basic and diluted:20232022
Net income (loss) attributable to controlling interests$(61,847)$79,792 
Denominator
Weighted-average common shares - basic common stock156,792 119,542 
Weighted-average common shares - diluted common stock156,792 131,149 
Net income (loss) per share - basic common stock$(0.39)$0.67 
Net income (loss) per share - diluted common stock$(0.39)$0.61 
Denominator
Weighted-average common shares - basic common stock156,792 119,542 
Stock options and other dilutive awards 11,607